Wound
Consumer Health > Wound treatments

Wound Treatments in Egypt

Egypt

Euromonitor International's Wound Treatments in Egypt market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.

Tables: 27  |  Publication date: Jun 2009
Cost: 
GBP560.00

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Product coverage

Other wound treatments; Sticking plasters

Table of contents

WOUND TREATMENTS IN EGYPT : MARKET INSIGHT

SECTOR DATA

Table 1 Sales of Wound Treatments by Subsector: Value 2003-2008

Table 2 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008

Table 3 Wound Treatments Company Shares by Value 2004-2008

Table 4 Wound Treatments Brand Shares by Value 2005-2008

Table 5 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013

Table 6 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013

LOCAL COMPANY PROFILES - EGYPT

AMOUN PHARMACEUTICAL INDUSTRY CO - OTC HEALTHCARE - EGYPT

STRATEGIC DIRECTION

KEY FACTS

Summary 1 Amoun Pharmaceutical Industry Co: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 2 Amoun Pharmaceutical Industry Co: Competitive Position 2008

ATOS PHARMA - OTC HEALTHCARE - EGYPT

STRATEGIC DIRECTION

KEY FACTS

Summary 3 Atos Pharma: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 4 Atos Pharma: Competitive Position 2008

EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO SAE (EIPICO) - OTC HEALTHCARE - EGYPT

STRATEGIC DIRECTION

KEY FACTS

Summary 5 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 6 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Competitive Position 2008

KAHIRA PHARMACEUTICAL & CHEMICAL INDUSTRIES CO - OTC HEALTHCARE - EGYPT

STRATEGIC DIRECTION

KEY FACTS

Summary 7 Kahira Pharmaceutical & Chemical Industries Co: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 8 Kahira Pharmaceutical & Chemical Co: Competitive Position 2008

PHARCO PHARMACEUTICALS - OTC HEALTHCARE - EGYPT

STRATEGIC DIRECTION

KEY FACTS

Summary 9 Pharco Pharmaceuticals: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 10 Pharco Pharmaceuticals: Competitive Position 2008

OTC HEALTHCARE IN EGYPT

EXECUTIVE SUMMARY

Dynamic growth in OTC healthcare in Egypt

The rigid control of the Ministry of Health is a constraint to sales

Egyptian companies and multinationals compete for market share

Distribution is only allowed through chemists/pharmacies

A bright forecast for OTC healthcare

KEY TRENDS AND DEVELOPMENTS

Rigid control by the Ministry of Health over the OTC healthcare market

Low purchasing power hinders sales of OTC healthcare products

Strike of chemists/pharmacies at the beginning of 2009

Lack of awareness of brands in the market

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 8 Life Expectancy at Birth 2003-2008

MARKET DATA

Table 9 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 10 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 11 OTC Healthcare Company Shares by Value 2004-2008

Table 12 OTC Healthcare Brand Shares by Value 2005-2008

Table 13 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 14 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 15 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 16 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

APPENDIX

OTC Registration and Classification

Vitamins & Dietary Supplements Registration and Classification

Self-medication and Preventative Medicine

Generics

DEFINITIONS

Summary 11 Research Sources

Change currency displayed
all prices excluding P&P
request more information

Available formats

  • Instant online access
  • Download PDF
  • Download Word document
research methodology

Get Acrobat Reader

click here to download Adobe Acrobat Reader 7.0

© Euromonitor International 2010